Company · CIK 0001615219 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Decoy Therapeutics Inc. · DCOY
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 AForm 4 → | Sep 2, 6:32 pm EDT | Jonathan I LieberDirector | 2,000 | — | — | 2,002 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 5:50 pm EDT | Frederick Pierce IIChief Executive Officer | 33,455 | — | — | 34,844 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 5:49 pm EDT | Peter Klaus MarschelChief Business Officer | 3,900 | — | — | 3,900 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 5:48 pm EDT | Mark J RosenblumChief Financial Officer | 9,682 | — | — | 11,363 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 5:46 pm EDT | Barbara Louise HibnerChief Scientific Officer | 4,216 | — | — | 4,216 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 5:45 pm EDT | Arnold C HanishDirector | 3,000 | — | — | 3,418 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 5:42 pm EDT | Paul LammersDirector | 2,000 | — | — | 2,001 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 5:41 pm EDT | Tess BurlesonDirector | 2,000 | — | — | 2,002 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 5:40 pm EDT | William K. McVicarDirector | 3,000 | — | — | 3,002 | — | |
| Aug 31, 2026 AForm 4 → | Sep 2, 5:39 pm EDT | Patricia G. GauthierDirector | 2,000 | — | — | 2,000 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.